|

IgPro20 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: HIZENTRA

Pipeline

Phase 2: 1

Top Sponsors

  • Memorial Sloan Kettering Cancer Center1

Indications

  • Hypogammaglobulinemia, Acquired1
  • Hypogammaglobulinemia1
  • Multiple Myeloma1
  • Cancer1

Basking Ridge, New Jersey1 trial

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Memorial Sloan Kettering Basking Ridge (All Protocol Activities)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.